Pulmocis 2 mg trousse pour préparation radiopharmaceutique

DRUG2 trials

Sponsors

Institut Gustave Roussy, Institut Gustave Roussy, Centre Hospitalier Regional Et Universitaire De Brest

Conditions

Non resectable Hepatocellular carcinoma (HCC)Pulmonary embolism

Phase 1

Ventilation/Perfusion PET/CT with Galligas and 68Ga-MAA for regional lung function assessment after pulmonary embolism

Not yet recruitingCTIS2024-518293-13-01

Centre Hospitalier Regional Et Universitaire De BrestPulmonary embolism

Target: 32Updated: 2025-01-28

Phase 2

Clinical investigation evaluating safety and efficacy of selective intra-arterial 166Holmium radiation therapy in combination with atezolizumab and bevacizumab for non resectable Hepatocellular carcinoma (HOLMBRAVE)

CompletedCTIS2024-511538-11-00

Institut Gustave Roussy, Institut Gustave RoussyNon resectable Hepatocellular carcinoma (HCC)

Start: 2023-02-07End: 2024-07-30Target: 40Updated: 2024-04-05